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AbstrACt
Objectives There are no established mortality risk equations 
specifically for emergency medical patients who are admitted 
to a general hospital ward. Such risk equations may be 
useful in supporting the clinical decision-making process. 
We aim to develop and externally validate a computer-
aided risk of mortality (CARM) score by combining the first 
electronically recorded vital signs and blood test results for 
emergency medical admissions.
Design Logistic regression model development and external 
validation study.
setting Two acute hospitals (Northern Lincolnshire and Goole 
NHS Foundation Trust Hospital (NH)—model development 
data; York Hospital (YH)—external validation data).
Participants Adult (aged ≥16 years) medical admissions 
discharged over a 24-month period with electronic National 
Early Warning Score(s) and blood test results recorded on 
admission.
results The risk of in-hospital mortality following emergency 
medical admission was 5.7% (NH: 1766/30 996) and 6.5% 
(YH: 1703/26 247). The C-statistic for the CARM score in 
NH was 0.87 (95% CI 0.86 to 0.88) and was similar in an 
external hospital setting YH (0.86, 95% CI 0.85 to 0.87) and the 
calibration slope included 1 (0.97, 95% CI 0.94 to 1.00).
Conclusions We have developed a novel, externally 
validated CARM score with good performance characteristics 
for estimating the risk of in-hospital mortality following 
an emergency medical admission using the patient’s first, 
electronically recorded, vital signs and blood test results. 
Since the CARM score places no additional data collection 
burden on clinicians and is readily automated, it may now be 
carefully introduced and evaluated in hospitals with sufficient 
informatics infrastructure.
IntrODuCtIOn  
Unplanned or emergency medical admis-
sions to hospital involve patients with a broad 
spectrum disease and illness severity.1 The 
appropriate early assessment and manage-
ment of such admissions can be a crit-
ical factor in ensuring high-quality care.2 
A number of scoring systems have been 
developed which may support this clin-
ical decision-making process, but few have 
been externally validated.1 We propose to 
develop a computer-aided risk of in-hospital 
mortality score, following emergency medical 
admission that automatically combines two 
routinely collected, electronically recorded, 
clinical datasets—vital signs and blood test 
results. There is some evidence to suggest 
that the results of routinely undertaken blood 
tests and/or vital signs data may be useful in 
predicting the risk of death.1 
In the UK National Health Service (NHS), 
the patient’s vital signs are monitored and 
summarised into a National Early Warning 
Score(s) (NEWS) that is mandated by the 
strengths and limitations of this study
 ► This study provides a novel computer-aided risk of 
mortality (CARM) score by combining the first elec-
tronically recorded vital signs and blood test results 
for emergency medical admissions.
 ► CARM is externally validated and places no addition-
al data collection burden on clinicians and is readily 
automated.
 ► About 20%–30% of admissions do not have both 
National Early Warning Score(s) and blood test 
results and so CARM is not applicable to these 
admissions.
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Royal College of Physicians (London).3 NEWS is derived 
from six physiological variables or vital signs—respira-
tion rate, oxygen saturations, any supplemental oxygen, 
temperature, systolic blood pressure, heart rate and level 
of consciousness (alert, voice, pain, unresponsive)—
which are routinely collected by nursing staff as an inte-
gral part of the process of care, usually for all patients, 
and then repeated thereafter depending on local hospital 
protocols.3 The use of NEWS is relevant because ‘patients 
die not from their disease but from the disordered physi-
ology caused by the disease’.4 NEWS points are allocated 
according to basic clinical observations and the higher 
the NEWS the more likely it is that the patient is devel-
oping a critical illness (see online supplementary material 
for further details of the NEWS). The clinical rationale 
for NEWS is that early recognition of deterioration in 
the vital signs of a patient can provide opportunities for 
earlier, more effective intervention. Furthermore, studies 
have shown that electronically collected NEWS are highly 
reliable and accurate when compared with paper-based 
methods.5–8
Blood tests are an integral part of clinical medicine, 
and are routinely undertaken during a patient’s stay in 
hospital. Typically, routine blood tests consist of a core list 
of seven biochemical and haematological tests (albumin, 
creatinine, potassium, sodium, urea, haemoglobin, white 
blood cell count) and, in the absence of contraindica-
tions and subject to patient consent, almost all patients 
admitted to hospital undergo these tests on admission. 
Furthermore, in the UK NHS creatinine blood test results 
are now used to identify patients at risk of acute kidney 
injury (AKI),9 which is an important cause of avoidable 
patient harm.10
In this paper, we investigate the extent to which the 
vital signs and blood test results of acutely ill patients 
can be used to predict the risk of in-hospital mortality 
following emergency admission to hospital. Our aim is 
to develop and validate an automated, computer-aided 
risk of mortality (CARM) model, using the patient’s first, 
electronically recorded, vital signs and blood test results, 
which are usually available within a few hours of emer-
gency admission without requiring any additional data 
items or prompts from clinicians. CARM, therefore, is 
designed for use in hospitals with sufficient informatics 
infrastructure.
MethODs
setting and data
Our cohorts of emergency medical admissions are from 
three acute hospitals which are approximately 100 
km apart in the Yorkshire and Humberside region of 
England—the Diana, Princess of Wales Hospital (n~400 
beds) and Scunthorpe General Hospital (n~400 beds) 
managed by the Northern Lincolnshire and Goole NHS 
Foundation Trust (NLAG) and York Hospital (YH) (n~700 
beds) (managed by York Teaching Hospitals NHS Foun-
dation Trust). The data from the two acute hospitals from 
NLAG are combined because this reflects how the hospi-
tals are managed and are referred to as NLAG Hospitals 
(NH), which essentially places our study in two acute 
hospitals. Our study hospitals (NH and YH) have been 
exclusively using electronic NEWS scoring since at least 
2013 as part of their in-house electronic patient record 
systems. We chose these hospitals because they had elec-
tronic NEWS, which are collected as part of the patient’s 
process of care and were agreeable to the study. We did 
not approach any other hospital.
We considered all adult (aged ≥16 years) emergency 
medical admissions, discharged during a 24-month 
period (1 January 2014 to 31 December 2015), with blood 
test results and NEWS. For each admission, we obtained 
a pseudonymised patient identifier, the patient’s age 
(years), sex (male/female), discharge status (alive/
dead), admission and discharge date and time and elec-
tronic NEWS. The NEWS ranged from 0 (indicating the 
lowest severity of illness) to 19 (the maximum NEWS 
value possible is 20). The admission/discharge date and 
electronically recorded NEWS are date and time stamped 
and the index NEWS was defined as the first electroni-
cally recorded score within ±24 hours of the admission 
time. The first blood test results were defined as the 
first full set of blood test results recorded within 4 days 
(96 hours) of admission (>90% of blood test results were 
within ±24 hours of admission—see online supplemen-
tary table S1).
For model development purposes, we were unable 
to consider emergency admissions without complete 
blood test results and NEWS recorded—this consti-
tuted 16.5% (6104/37 100) of records in NH and 28.6% 
(10 504/36 751) of records in YH. We excluded records 
for the following reasons: (1) records where the first 
NEWS was after 24 hours of admission and/or (2) where 
the first blood test was after 4 days of admission because 
these ‘delayed’ data were considered less likely to reflect 
the sickness profile of patients on admission. Moreover, 
the time from admission to first blood test results was 
usually several hours earlier than the actual time of admis-
sion because blood tests can be ordered in the emergency 
department before formal admission (see online supple-
mentary figure S1).
Development of a CArM score
We began with exploratory analyses including line plots 
and box plots that showed the relationship between 
covariates and risk of in-hospital death in our hospitals. 
We developed a logistic regression model, known as 
CARM, to predict the risk of in-hospital death with the 
following covariates: age (years), sex (male/female), 
NEWS (including its components, plus diastolic blood 
pressure, as separate covariates), blood test results 
(albumin, creatinine, haemoglobin, potassium, sodium, 
urea and white cell count) and AKI score. The primary 
rationale for using these variables is that they are routinely 
collected as part of process of care and their inclusion in 
our statistical models is on clinical grounds as opposed 
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to the statistical significance of any given covariate. The 
widespread use of these variables in routine clinical care 
means that our model is more likely to be generalisable 
to other settings.
We used the qladder function (Stata, StatCorp, 2014), 
which displays the quantiles of transformed variable 
against the quantiles of a normal distribution according to 
the ladder powers  
(
x3, x2, x1, x,
√
x, log
(
x
)
, x−1, x−2, x−3
)
  
for each variable continious covariate and chose the 
following transformations: (creatinine)−1/2, loge(potas-
sium), loge(white cell count), loge(urea), loge(respiratory 
rate), loge(pulse rate), loge(systolic blood pressure) and 
loge(diastolic blood pressure). We used an automated 
approach to search for all two-way interactions and incor-
porated those interactions which were statistically signifi-
cant (p<0.001) implemented in the MASS library11 in R.12
We developed the CARM model to predict the risk of 
in-hospital mortality following emergency medical admis-
sion using data from NH (the development dataset) and 
we externally validated this model, reporting discrimi-
nation and calibration characteristics,13 using data from 
another hospital (YH) (the external validation dataset). 
The data from YH are not used for model development 
but as an external validation dataset only. We internally 
validated the CARM using a bootstrapping method that 
is implemented in the rms library14 in R to estimate statis-
tical optimism.13 14
Discrimination relates to how well a model can separate 
(or discriminate between), those who died and those who 
did not. Calibration measures a model's ability to generate 
predictions that are on average close to the average 
observed outcome. Overall statistical performance was 
assessed using the scaled Brier score, which incorporates 
both discrimination and calibration.13 The Brier score 
is the squared difference between actual outcomes and 
predicted risk of death, scaled by the maximum Brier 
score such that the scaled Brier score ranges from 0% to 
100%. Interpretation of the scaled Brier score is similar to 
R2. Higher values indicate superior models. Calibration is 
the relationship between the observed and predicted risk 
of death and can be readily seen on a scatter plot (y-axis 
observed risk, x-axis predicted risk). Perfect predictions 
should be on the 45° line. The intercept (a) and slope 
(b) of this line gives an assessment of ‘calibration-in-the-
large’.15 At model development, a=0 and b=1, but at vali-
dation, calibration-in-the-large problems are indicated if 
a is not 0 and if b is more/less than 1 as this reflects prob-
lems of under/over prediction.16
The concordance statistic (C-statistic) is a commonly 
used measure of discrimination. For a binary outcome, 
the C-statistic is the area under the receiver operating 
characteristics (ROC) curve. The ROC curve is a plot of 
the sensitivity (true positive rate) versus 1−specificty (false 
positive rate), for consecutive predicted risks.13 The area 
under the ROC curve is interpreted as the probability 
that a deceased patient has a higher predicted risk of 
death than a randomly chosen non-deceased patient. A 
C-statistic of 0.5 is no better than tossing a coin, while a 
perfect model has a C-statistic of 1. The higher the C-sta-
tistic, the better the model. In general, values <0.7 are 
considered to show poor discrimination, values of 0.7–0.8 
can be described as reasonable and values >0.8 suggest 
good discrimination.17 The 95% CI for the C-statistic 
was derived using DeLong’s method as implemented in 
the pROC library18 in R.12 Box plots showing the risk of 
death for those discharged alive and dead are a simple 
way to visualise the discrimination of each model. The 
difference in the mean predicted risk of death for those 
who were discharged alive and dead is a measure of the 
discrimination slope. The higher the slope, the better the 
discrimination.13 We followed the TRIPOD guidelines for 
model development and validation.19 All analyses were 
carried using R12 and Stata.
Patient and public involvement
A workshop with a patient and service user group, linked 
to the University of Bradford, was involved at the start of 
this project to co-design the agenda for the patient and 
staff focus groups, which were subsequently held at each 
hospital site. Patients were invited to attend the patient 
focus group through existing patient and public involve-
ment groups. The criteria used for recruitment to these 
focus group was any member of the public who had been 
a patient or carer in the last 5 years. The patient and 
public voice continued to be included throughout the 
project with three patient representatives invited to sit on 
Table 1 Number and mortality of emergency medical admissions included/excluded
Characteristic
Development dataset Validation dataset
N (%) N (%)
Total emergency medical admissions 37 100 36 751
Excluded: no NEWS recorded (%) 1305 (3.5) 772 (2.1)
Excluded: first NEWS after 24 hours of admission (%) 634 (1.7) 172 (0.5)
Excluded: first blood test results after 4 days of admission (%) 464 (1.3) 673 (1.8)
Excluded: no or incomplete blood test results recorded (%) 3701 (10.0) 8887 (24.2)
Total excluded (%) 6104 (16.5) 10 504 (28.6)
Total included (%) 30 996 (83.5) 26 247 (71.4)
NEWS, National Early Warning Score(s).
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the project steering group. Participants will be informed 
of the results of this study through the patient and public 
involvement leads at each hospital site and the project 
team have met with the Bradford patient and service user 
group to discuss the results.
results
Cohort description
We considered emergency medical admissions in each 
hospital (NH: n=37 100, YH: n=36 751) over the 24-month 
period. Of these, 16.5% (6104/37 100) in NH and 28.6% 
(10 504/36 751) in YH were not eligible for our study 
because they did not have NEWS recorded within ±24 hours 
of admission and/or full complement of blood test results 
within ±96 hours of admission (see table 1, online supple-
mentary table S1 and figure S1). At YH, 24.2% of records 
were excluded because no or incomplete blood test results 
were recorded compared with only 10% in NH. Exclusions 
due to lack of NEWS data were less marked between YH 
and NH (see online supplementary table S2 for character-
istic of emergency admissions with incomplete data).
The in-hospital mortality was 5.7% (1766/30 996) in 
NH and 6.5% (1703/26 247) in YH. The age, sex, NEWS 
and blood test results profile is shown table 2. Admissions 
in YH were older, with higher NEWS, higher AKI scores 
(AKI stage 3 is more common than stage 2 in YH) but 
higher albumin blood test results than NH. YH has a 
renal unit whereas NH does not.
Table 2 Characteristics of emergency admissions for development and validation datasets
Characteristic
Development dataset (NH) Validation dataset (YH)
Discharged alive Discharged died Discharged alive Discharged died
N 29 230 1766 24 544 1703
Median length of stay (days) (IQR) 4.3 (8.3) 8.3 (13.3) 3.9 (7.7) 8.1 (14.1)
Male (%) 14 557 (49.8) 887 (50.2) 11 646 (47.5) 845 (49.6)
Mean NEWS (SD) 2.1 (2.2) 4.5 (3.2) 2.5 (2.5) 5.0 (3.6)
Alertness
  Alert (%) 28 788 (98.5) 1613 (91.3) 23 953 (97.6) 1503 (88.3)
  Pain (%) 80 (0.3) 31 (1.8) 131 (0.5) 49 (2.9)
  Voice (%) 315 (1.1) 83 (4.7) 357 (1.5) 106 (6.2)
  Unconscious (%) 47 (0.2) 39 (2.2) 103 (0.4) 45 (2.6)
AKI score
  0 (%) 27 063 (92.6) 1326 (75.1) 22 133 (90.2) 936 (55.0)
  1 (%) 1358 (4.7) 204 (11.6) 1482 (6.0) 451 (26.5)
  2 (%) 429 (1.5) 129 (7.3) 369 (1.5) 191 (11.2)
  3 (%) 380 (1.3) 107 (6.1) 560 (2.3) 125 (7.3)
Oxygen supplementation (%) 5364 (18.4) 900 (51.0) 2549 (10.4) 582 (34.2)
Mean age (years) (SD) 66.2 (19.5) 79.8 (11.1) 67.5 (19.4) 80 (11.7)
Mean albumin (g/L) (SD) 33.7 (5.9) 27.3 (6.4) 38.2 (5.7) 32.9 (6)
Mean creatinine (μmol/L) (SD) 103.3 (78.2) 148.9 (124.4) 100.8 (90.6) 138.7 (119)
Mean haemoglobin (g/L) (SD) 127.8 (22.2) 117.1 (22.8) 125.2 (22) 117.1 (23.2)
Mean potassium (mmol/L) (SD) 4.1 (0.6) 4.3 (0.8) 4.3 (0.6) 4.4 (0.8)
Mean sodium (mmol/L) (SD) 137 (5.1) 136 (7) 136.6 (4.6) 136.1 (6.2)
Mean white cell count (109 cells/L) (SD) 9.8 (6.5) 13.2 (13.3) 10.2 (10.7) 13.9 (21.1)
Mean urea (mmol/L) (SD) 7.5 (5.6) 14.1 (10.5) 7.8 (5.6) 13.3 (8.9)
Mean respiratory rate (breaths per min) (SD) 18 (3.5) 20.1 (4.8) 18.6 (4.6) 21.7 (6.8)
Mean temperature (°C) (SD) 36.5 (0.7) 36.3 (0.8) 36.3 (0.8) 36.1 (1.1)
Mean systolic pressure (mm Hg) (SD) 129.6 (22.7) 119.8 (24.8) 136.1 (27.2) 128.5 (30.3)
Mean diastolic pressure (mm Hg) (SD) 75 (14.8) 69.5 (15.8) 75.4 (15.5) 71.3 (17.7)
Mean pulse rate (beats per min) (SD) 81.3 (17.7) 86.5 (19.7) 86.2 (20.9) 92.1 (23.3)
Mean % oxygen saturation (SD) 96.0 (2.9) 94.6 (4.7) 96.3 (2.9) 95.0 (4.4)
AKI, acute kidney injury; NEWS, National Early Warning Score(s); NH, Northern Lincolnshire and Goole NHS Foundation Trust Hospital; YH, 
York Hospital.
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Online supplementary figures S2 to S5 show box plots 
and line plots for each continuous (untransformed) 
covariate that was included in the CARM model for NH 
and YH, respectively. The box plots (see online supple-
mentary figures S2 and S3) show a similar pattern in each 
hospital. Compared with patients discharged alive, the 
deceased patients were aged older, with lower albumin, 
haemoglobin and sodium values and higher creatinine, 
potassium, white cell count and urea values. NEWS was 
higher in deceased patients compared with patients 
discharged alive, as respiratory rate and pulse rate were 
higher in deceased patients. However, the temperature, 
blood pressure and oxygen saturation were lower in 
deceased patients. The line plots in online supplemen-
tary figures S4 and S5 show that the relationship between 
a given continuous covariate and the risk of death is 
similar in each hospital.
statistical modelling of CArM
We assessed the performance of the CARM model to 
predict the risk of in-hospital mortality. The model coef-
ficients in logit scale with examples are shown in online 
supplementary table S3. Table 3 shows the performance 
of the model in the development and validation dataset. 
Figure 1 shows the ROC plots of CARM in the develop-
ment and validation datasets (see online supplemen-
tary figure S6 for ROC plots comparing CARM vs NEWS). 
The C-statistic was high in the development dataset 0.87 
(95% CI 0.86 to 0.88) and the external validation dataset 
0.86 (95% CI 0.85 to 0.87). Likewise, the scaled Brier 
score and discrimination were similar in the develop-
ment and external validation datasets. The calibration 
slope is 0.97 (95% CI 0.94 to 1.00), which is good (see 
online supplementary figure S7). The final CARM model, 
which is not intended for paper-based use, is shown in the 
online supplementary figure S7).
We excluded 10.0% (NH) and 24.2% (YH) of emer-
gency admissions from the development and validation 
dataset, respectively, because they had no or incom-
plete set of blood test results reported. We examined 
the performance of the CARM model in these excluded 
records by first imputing age and sex-specific median 
blood test results, and then applying the CARM model to 
these admissions only. The last column in table 3 shows 
the subsequent C-statistics in these imputed records only. 
The C-statistics for these imputed records were not mark-
edly different in the development and validation dataset 
Table 3 Comparing calibration and discrimination of CARM model to predict in-hospital mortality in development and 
validation datasets
Dataset
Mean 
predicted 
risk: alive
Mean 
predicted 
risk: died*
Discrimination 
slope†
Scaled Brier 
score AUC (95% CI)
Median imputed 
AUC (95% CI)
Development 
dataset
0.047 0.229 0.183 0.175 0.874‡ (0.866 to 0.881) 0.915 (0.888 to 0.941)
Validation 
dataset
0.053 0.231 0.178 0.165 0.861 (0.852 to 0.869) 0.900 (0.880 to 0.919)
*Died in-hospital following emergency admission.
†Mean predicted risk difference between who discharged died and discharged alive.
‡Corrected optimism (original=0.874 and corrected=0.873).
AUC, area under the curve; CARM, computer-aided risk of mortality.
Figure 1 Area under the receiver operating characteristic curve for development dataset (0.87) and validation dataset (0.86).
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(see online supplementary figure S8 for corresponding 
ROC plots).
Table 4 shows the sensitivity, specificity and positive 
and negative predictive values along with likelihood 
ratio (LR+/LR−) for a selected range of cut-off values 
for the risk of dying, which tentatively suggests that 
a threshold risk of 8% provides a reasonable balance 
between sensitivity (around 70%) and specificity (>80% 
in development and validation datasets—see table 4 
and online supplementary figure S9). Furthermore, the 
CARM model performance is good in each hospital in 
various subgroups such as by sex, age, seasons, longer 
versus shorter length of stay admissions, day of the week 
and 16 Charlson Comorbidity Index (CCI) disease 
groups (see online supplementary table S4).
DIsCussIOn
We have shown that it is feasible to use the first electron-
ically recorded vital signs and blood test results of an 
emergency medical patient to predict the risk of in-hos-
pital mortality following emergency medical admission. 
We developed our CARM model in one hospital and 
externally validated in data from another hospital. We 
found that CARM has good performance and our find-
ings tentatively suggest that a cut-off of 8% predicted risk 
of in-hospital mortality death appears to strike a reason-
able balance between sensitivity and specificity.
While several previous studies1 have used blood test 
results20–27 or patient physiology28 29 to predict the risk of 
in-hospital mortality, few studies have combined these two 
data sources2 30–32 and even fewer reported external valida-
tion.1 Our study is based on data from two different hospi-
tals with material differences in recording of blood test 
results but still yielding similar performance of CARM. 
This suggests that our approach, which merits further 
study, may be generalisable to other UK NHS hospitals 
with electronically recorded blood test results and NEWS, 
especially as the use of NEWS in the UK NHS is mandated 
and that our approach does not rely on reference ranges 
from blood tests which can vary between hospitals. 
Indeed, a recent paper with sepsis as the outcome vari-
able also showed promising results by combining the first 
blood test results and NEWS.33
There are a number of limitations in our study. There 
appears to be a systematic difference in the prevalence 
of oxygen supplementation in the development and vali-
dation datasets, which may warrant further investigation. 
However, the prevalence ratios (dead/alive) are similar in 
both groups (2.77 and 3.29 for NH and YH, respectively) 
and therefore this should have no significant detrimental 
effect on the validity of our model. Although we focused 
on in-hospital mortality (because we aimed to aid clinical 
decision making in the hospital), the impact of this selec-
tion bias needs to be assessed by capturing out-of-hospital 
mortality by linking death certification data and hospital 
data. CARM, like other risk scores, can only be an aid 
to the decision-making process of clinical teams1 17 and T
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its usefulness in clinical practice remains to be seen. We 
found that up to about quarter  of emergency medical 
admissions had no (or an incomplete set of) recorded 
blood test results for whom we tested a simple median 
imputation strategy without knowing why such data were 
missing. We found that the performance of CARM did 
not materially deteriorate in these admissions. We do not 
suggest that our imputation method is an optimal impu-
tation strategy. Rather, we offer it as a simple, pragmatic, 
preliminary imputation strategy, which is akin to the 
AKI detection algorithm which also imputes the median 
creatinine value where required.34 Further work on how 
to optimally address the issue of missing data is required. 
We did not undertake an imputation exercise for patients 
with no recorded NEWS because they constituted a much 
smaller proportion of missing data (<5%), and NEWS is 
not recommended in patients requiring immediate resus-
citation, direct admission to intensive care, and patients 
with end-stage renal failure or with acute intracranial 
conditions.35 We have used the first set of electronically 
recorded vital signs and blood test results to develop 
CARM, but updating CARM scores in real-time when new 
data become available is likely to be important to clinical 
teams and so warrants further study. Finally, our external 
validation was undertaken by the same research team in 
a similar context of the NHS. Further external validation 
by different research teams in different settings would be 
useful.
We have designed CARM to be used in hospitals with 
sufficient informatics infrastructure (eg, electronic health 
records).36 37 CARM is not targeting specific emergency 
medical patients only. Rather, we are seeking to raise situ-
ational awareness of the risk of death in-hospital as early 
as possible, without requiring any additional data items 
or prompts from clinicians. While we have demonstrated 
that CARM has potential, we have yet to test its use in 
routine clinical practice. This is important because we 
need to demonstrate that CARM does more ‘good’ than 
‘harm’ in practice.36 37 For example, while routine blood 
tests are not indicated in a considerable number of emer-
gency medical admissions, it is nevertheless possible that 
for a given patient, some clinicians (eg, less experienced) 
may be tempted to order routine blood tests so that they 
can obtain a CARM score to support their clinical deci-
sion-making process. So, the next phase of this work is to 
field test CARM by carefully engineering it into routine 
clinical practice to see if it does enhance the quality of 
care for acutely ill patients, while noting any unintended 
consequences.
COnClusIOn
We have developed a novel, externally validated CARM 
model, with good performance for estimating the risk of 
in-hospital mortality following emergency medical admis-
sion using the patient’s first, electronically recorded, vital 
signs and blood test results. Since CARM places no addi-
tional data collection burden on clinicians and is readily 
automated, it may now be carefully introduced and evalu-
ated in hospitals with electronic health records.
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